Epigenetic Therapy

Epigenetic therapy is the use of drugs or other epigenome-influencing techniques to treat medical conditions such as cancer, heart disease, diabetes, and mental illnesses. Epigenetic therapies are among the most active areas of preclinical and clinical cancer research evidence to their potential of specifically targeting chromatin-mediated disease mechanisms. It is expected that these therapies will have fewer side effects than conventional cytotoxic chemotherapies. Several classes of drugs have emerged, and several are on-going development.

The DNMT inhibitors 5-azacytidine and 5-aza-20-deoxycytidine have both been approved by the FDA for the treatment of various forms of cancer. These drugs have been evident to reactivate the cellular antitumor systems which are repressed by cancer, hence enabling the body to weaken the tumor.

    Related Conference of Epigenetic Therapy

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Epigenetic Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in